289 related articles for article (PubMed ID: 36193764)
1. Biomineralized Two-Enzyme Nanoparticles Regulate Tumor Glycometabolism Inducing Tumor Cell Pyroptosis and Robust Antitumor Immunotherapy.
Zhang S; Zhang Y; Feng Y; Wu J; Hu Y; Lin L; Xu C; Chen J; Tang Z; Tian H; Chen X
Adv Mater; 2022 Dec; 34(50):e2206851. PubMed ID: 36193764
[TBL] [Abstract][Full Text] [Related]
2. Biomimetic black phosphorus quantum dots-based photothermal therapy combined with anti-PD-L1 treatment inhibits recurrence and metastasis in triple-negative breast cancer.
Zhao P; Xu Y; Ji W; Zhou S; Li L; Qiu L; Qian Z; Wang X; Zhang H
J Nanobiotechnology; 2021 Jun; 19(1):181. PubMed ID: 34120612
[TBL] [Abstract][Full Text] [Related]
3. Nanomicelle protects the immune activation effects of Paclitaxel and sensitizes tumors to anti-PD-1 Immunotherapy.
Yang Q; Shi G; Chen X; Lin Y; Cheng L; Jiang Q; Yan X; Jiang M; Li Y; Zhang H; Wang H; Wang Y; Wang Q; Zhang Y; Liu Y; Su X; Dai L; Tang M; Li J; Zhang L; Qian Z; Yu D; Deng H
Theranostics; 2020; 10(18):8382-8399. PubMed ID: 32724476
[TBL] [Abstract][Full Text] [Related]
4. Near-Infrared Light-Triggered Thermoresponsive Pyroptosis System for Synergistic Tumor Immunotherapy.
Zhu G; Zheng P; Wang M; Xie Y; Sun Q; Gao M; Li C
Adv Healthc Mater; 2024 Feb; 13(4):e2302095. PubMed ID: 37975590
[TBL] [Abstract][Full Text] [Related]
5. mRNA lipid nanoparticle-mediated pyroptosis sensitizes immunologically cold tumors to checkpoint immunotherapy.
Li F; Zhang XQ; Ho W; Tang M; Li Z; Bu L; Xu X
Nat Commun; 2023 Jul; 14(1):4223. PubMed ID: 37454146
[TBL] [Abstract][Full Text] [Related]
6. A generally minimalist strategy of constructing biomineralized high-efficiency personalized nanovaccine combined with immune checkpoint blockade for cancer immunotherapy.
Zhang S; Feng Y; Meng M; Li Z; Li H; Lin L; Xu C; Chen J; Hao K; Tang Z; Tian H; Chen X
Biomaterials; 2022 Oct; 289():121794. PubMed ID: 36113330
[TBL] [Abstract][Full Text] [Related]
7. Integrin α
Chen H; Zhao L; Fu K; Lin Q; Wen X; Jacobson O; Sun L; Wu H; Zhang X; Guo Z; Lin Q; Chen X
Theranostics; 2019; 9(25):7948-7960. PubMed ID: 31695808
[TBL] [Abstract][Full Text] [Related]
8. Programmed Targeting Pyruvate Metabolism Therapy Amplified Single-Atom Nanozyme-Activated Pyroptosis for Immunotherapy.
Niu R; Liu Y; Xu B; Deng R; Zhou S; Cao Y; Li W; Zhang H; Zheng H; Song S; Wang Y; Zhang H
Adv Mater; 2024 Jun; 36(24):e2312124. PubMed ID: 38314930
[TBL] [Abstract][Full Text] [Related]
9. Platinum Prodrug Nanoparticles with COX-2 Inhibition Amplify Pyroptosis for Enhanced Chemotherapy and Immune Activation of Pancreatic Cancer.
Yu B; Wang Y; Bing T; Tang Y; Huang J; Xiao H; Liu C; Yu Y
Adv Mater; 2024 Mar; 36(11):e2310456. PubMed ID: 38092007
[TBL] [Abstract][Full Text] [Related]
10. A Mild Hyperthermia Hollow Carbon Nanozyme as Pyroptosis Inducer for Boosted Antitumor Immunity.
Tao N; Jiao L; Li H; Deng L; Wang W; Zhao S; Chen W; Chen L; Zhu C; Liu YN
ACS Nano; 2023 Nov; 17(22):22844-22858. PubMed ID: 37942890
[TBL] [Abstract][Full Text] [Related]
11. Combination of ultrasound-based mechanical disruption of tumor with immune checkpoint blockade modifies tumor microenvironment and augments systemic antitumor immunity.
Abe S; Nagata H; Crosby EJ; Inoue Y; Kaneko K; Liu CX; Yang X; Wang T; Acharya CR; Agarwal P; Snyder J; Gwin W; Morse MA; Zhong P; Lyerly HK; Osada T
J Immunother Cancer; 2022 Jan; 10(1):. PubMed ID: 35039461
[TBL] [Abstract][Full Text] [Related]
12. Sodium Bicarbonate Nanoparticles for Amplified Cancer Immunotherapy by Inducing Pyroptosis and Regulating Lactic Acid Metabolism.
Ding B; Zheng P; Tan J; Chen H; Meng Q; Li J; Li X; Han D; Li Z; Ma X; Ma P; Lin J
Angew Chem Int Ed Engl; 2023 Oct; 62(40):e202307706. PubMed ID: 37587061
[TBL] [Abstract][Full Text] [Related]
13. Regulating the immunosuppressive tumor microenvironment to enhance breast cancer immunotherapy using pH-responsive hybrid membrane-coated nanoparticles.
Gong C; Yu X; Zhang W; Han L; Wang R; Wang Y; Gao S; Yuan Y
J Nanobiotechnology; 2021 Feb; 19(1):58. PubMed ID: 33632231
[TBL] [Abstract][Full Text] [Related]
14. Study and analysis of antitumor resistance mechanism of PD1/PD-L1 immune checkpoint blocker.
Wang Z; Wu X
Cancer Med; 2020 Nov; 9(21):8086-8121. PubMed ID: 32875727
[TBL] [Abstract][Full Text] [Related]
15. Mitochondria-Targeting Polymer Micelle of Dichloroacetate Induced Pyroptosis to Enhance Osteosarcoma Immunotherapy.
Jin J; Yuan P; Yu W; Lin J; Xu A; Xu X; Lou J; Yu T; Qian C; Liu B; Song J; Li L; Piao Y; Xie T; Shen Y; Tao H; Tang J
ACS Nano; 2022 Jul; 16(7):10327-10340. PubMed ID: 35737477
[TBL] [Abstract][Full Text] [Related]
16. Pyroptosis: A road to next-generation cancer immunotherapy.
Fang Y; Tang Y; Huang B
Semin Immunol; 2023 Jul; 68():101782. PubMed ID: 37302166
[TBL] [Abstract][Full Text] [Related]
17. Sensitizing tumors to anti-PD-1 therapy by promoting NK and CD8+ T cells via pharmacological activation of FOXO3.
Chung YM; Khan PP; Wang H; Tsai WB; Qiao Y; Yu B; Larrick JW; Hu MC
J Immunother Cancer; 2021 Dec; 9(12):. PubMed ID: 34887262
[TBL] [Abstract][Full Text] [Related]
18. Pyroptosis Induction with Nanosonosensitizer-Augmented Sonodynamic Therapy Combined with PD-L1 Blockade Boosts Efficacy against Liver Cancer.
Zhang N; Zeng W; Xu Y; Li R; Wang M; Liu Y; Qu S; Ferrara KW; Dai Z
Adv Healthc Mater; 2024 Mar; 13(7):e2302606. PubMed ID: 37987462
[TBL] [Abstract][Full Text] [Related]
19. Combined Inhibition of TGF-β Signaling and the PD-L1 Immune Checkpoint Is Differentially Effective in Tumor Models.
Sow HS; Ren J; Camps M; Ossendorp F; Ten Dijke P
Cells; 2019 Apr; 8(4):. PubMed ID: 30959852
[TBL] [Abstract][Full Text] [Related]
20. Combination cancer immunotherapy targeting TNFR2 and PD-1/PD-L1 signaling reduces immunosuppressive effects in the microenvironment of pancreatic tumors.
Zhang X; Lao M; Xu J; Duan Y; Yang H; Li M; Ying H; He L; Sun K; Guo C; Chen W; Jiang H; Zhang X; Bai X; Liang T
J Immunother Cancer; 2022 Mar; 10(3):. PubMed ID: 35260434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
